While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

Two counties in the Charlotte area have filed lawsuits in the last few weeks over the price of insulin. Gaston County and ...

After turning over more than 1,300 documents to the Federal Trade Commission, the fast food giant is turning its attention to subpoenas from pharmacy benefit managers the agency accuses of ...

“Our internal and external experts all believe that the implementational time frame, while not as fast as we had hoped, are ...

Minnesota Attorney General Keith Ellison and pharmaceutical company Novo Nordisk reached a settlement to cap insulin costs at ...

BISMARCK, N.D. (North Dakota Monitor) – The North Dakota House of Representatives voted 59-27 on Thursday for a bill to lower ...

Cross-industry collaboration is key to fighting rising costs for consumers. The Fast Company Impact Council is a private ...

Over the past decade, the rising cost of insulin epitomized the broader systemic issue of higher healthcare out-of-pocket costs that prevented many Americans from accessing essential care.

Biosimilar insulin glargine access in Europe correlates with significant price reductions of originator products, enhancing affordability and accessibility. The study observed a 21.6% average ...

A handful of lawmakers passionately shared anecdotes surrounding high insulin costs before the House went against a committee ...